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Microglia are essential for the development and function of the adult brain. Microglia arise 
from erythro-myeloid precursors in the yolk sac and populate the brain rudiment early 
during development. Unlike monocytes that are constantly renewed from bone marrow 
hematopoietic stem cells throughout life, resident microglia in the healthy brain persist 
during adulthood via constant self-renewal. Their ontogeny, together with the absence of 
turnover from the periphery and the singular environment of the central nervous system, 
make microglia a unique cell population. Supporting this notion, recent genome-wide 
transcriptional studies revealed specific gene expression profiles clearly distinct from 
other brain and peripheral immune cells. Here, we highlight the breakthrough studies 
that, over the last decades, helped elucidate microglial cell identity, ontogeny, and func-
tion. We describe the main techniques that have been used for this task and outline the 
crucial milestones that have been achieved to reach our actual knowledge of microglia. 
Furthermore, we give an overview of the “microgliome” that is currently emerging thanks 
to the constant progress in the modern profiling techniques.
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iNTRODUCTiON
Until the beginning of the XXI century, the central nervous system (CNS) was seen as an immune-
privileged site sealed by the blood–brain barrier, a barrier that was thought to prevent peripheral 
immune cells infiltration (1). Over the past years, thanks to rapid progress in concepts and new 
techniques, the idea of the brain as an immune-isolated organ has changed. Specifically, the recent 
discovery of a meningeal lymphatic system as a pathway allowing the trafficking of immune cells in 
the brain was the missing link between the brain and the immune system (2, 3).
Distinct populations of resident macrophages colonize almost all the tissues in the body, including 
the CNS (4, 5). The CNS macrophage populations comprise microglia, perivascular macrophages, 
meningeal macrophages, and choroid plexus macrophages, though microglia are the only myeloid 
cells residing in the healthy CNS parenchyma (6, 7). Although sharing a common lineage with 
monocyte-derived macrophages, microglia’s unique ontogeny clearly distinguishes them from 
other myeloid cells. Microglia arise from erythro-myeloid precursors in the embryonic yolk sac and 
populate the embryonic brain early during development (embryonic day 9.5) (8). Unlike monocytes, 
FigURe 1 | Schematic representation of microglial functional states in the healthy murine brain. Microglia arise from erythro-myeloid precursors in the 
embryonic yolk sac and populate the brain rudiment early during development. Microglial cell population is maintained by self-renewal, without the contribution of 
bone marrow-derived progenitors. In the adult healthy brain, microglia continuously survey the brain and readily react to any potential threat to the CNS 
homeostasis. Phagocytic microglia can detect and quickly remove damaged or dying neurons, preventing further damage to neighboring cells. During 
developmental stages, microglia phagocytic capacity is particularly important to prune supernumerary synapses. Microglia has also been suggested to modulate 
neuronal activity by influencing synapse transmission (synaptic stripping). Under specific conditions, microglia are able to remove dysfunctional synapses by 
physically interacting with functional neurons.
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which are constantly renewed from bone marrow hematopoietic 
stem cells throughout life, resident microglial cells in the healthy 
adult brain persist during adulthood via constant self-renewal 
without turnover from circulating blood progenitors (Figure 1) 
(8–10). Recent genomic and transcriptomic analysis additionally 
revealed the uniqueness of microglia, which possess specific 
genetic signatures that are clearly distinct from other brain and 
peripheral immune cells (11–20).
Microglia are non-neuronal cells belonging to the glial 
population of CNS cells. They comprise between 5 and 20% of 
the glial cells, approximately 10% of the cells in the brain, being 
as numerous as neurons (6, 21). Under physiological condi-
tions, microglial cells play fundamental roles during neuronal 
development, adult neurogenesis, and in modulating synaptic 
transmission (Figure 1) (22–27). As the resident immune cells of 
the brain parenchyma, microglia act as central communicators 
between the nervous and the immune system, as they are the 
first sentinels protecting against invading pathogens and tissue 
damage (Figure 1) (28). The rise of innovative imaging, genetic, 
and immunological tools brought to light the remarkable high 
dynamism and plasticity of microglial cells under physiological 
conditions unmasking their crucial role in maintaining brain 
homeostasis. In the healthy mammalian brain, the so-called 
“resting” microglia are characterized by a ramified morphology, 
small cellular bodies, almost no cytoplasm, and slim branching 
processes bounded in fine protrusions. The majority of micro-
glia occupies their own territory that does not overlap with the 
neighboring cells (29). Microglia are ubiquitously distributed 
throughout the adult CNS, yet they show regional diversities as 
they follow differences of high (such as substantia nigra) and low 
(such as cerebellum) densities (21). Two-photon imaging in vivo 
studies revealed that these ramified microglia are highly active, 
continuously extending and retracting their fine processes, and 
scanning the CNS microenvironment without disturbing the 
neuronal fine wire. This notable movement activity sets micro-
glia as the fastest moving structures in the adult healthy brain, 
monitoring the entire brain parenchyma in less than four hours 
(30, 31).
Equipped with their branched morphology, microglia read-
ily react to any potential threat to the CNS homeostasis, such 
as pathogens, trauma, or neuronal dysfunctions by undergoing 
morphological, genetic, and functional changes, usually referred 
as microglia “activation.” “Activated” microglia exhibit migratory, 
proliferative, and phagocytic properties as well as the capacity 
to release chemokines, cytokines, neurotrophic factors and 
to present antigens (28). Consequently, a proper and effective 
microglial function is crucial for CNS homeostasis not only under 
healthy conditions, but also during threatening events. Similarly 
to macrophages, in an attempt to simplify the intrinsic spectrum 
of microglial activation states, it has been assessed for several 
years that, under defined environmental stimuli, microglia adopt 
a “classical” (M1-like) or an “alternative” (M2-like) activation 
state, depending on the nature of the stimulus they encounter. 
As their corresponding states in macrophages, “classical” acti-
vated microglia have been associated with antimicrobial activity 
through a classical inflammatory reaction driven by the produc-
tion of proinflammatory mediators, whereas “alternative” polar-
ized microglia have been related to tissue repair and homeostasis 
restoration (7). However, such dichotomous paradigm represents 
the extremes of a large spectrum of activation states and is often 
related to inflammatory reactions and morphological changes, 
rather than reflecting the microglial physiological and functional 
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status (32). Furthermore, at present, it is becoming more and more 
evident that “classical” or “alternative” activated microglia per se 
are barely present in vivo under healthy or diseased conditions 
(12, 33). In line with these evidences, concepts such as “resting” 
and “activated” microglia are currently considered simplistic and 
archaic as they do neither reflect microglia movement dyna-
mism nor their functional plasticity [reviewed in Ref. (34–37)]. 
In this context, the microglia classification is currently reshaped 
in order to identify microglial cell phenotypes based, for example, 
on their inducing stimuli, such as MLPS or MIL4 when stimulated, 
respectively, with LPS or IL4, instead of relying on microglia/
macrophages pre-defined states (38, 39).
In order to follow this rapid advancement of microglia 
understanding and having in mind the magnitude to which 
accurate methodologies and innovative techniques can impact 
our knowledge, we aim here to review the breakthrough steps 
achieved in microglia research, from the past to the present 
days. This article is not meant to cover the history of microglia 
groundwork, but it is rather projected to highlight the steps that 
contributed to elucidate their identity, ontogeny, and function. 
We will specifically discuss the impact of the recent genome-
wide expression profiling data, which revealed transcriptional 
microglial cells uniqueness when compared to peripheral 
immune cells.
FiNDiNg AND CHARACTeRiZiNg 
MiCROgLiA
The Concept of Neuroglia
How important is the historical context in shaping our current 
understanding of microglial biology? From the original challenge 
of “placing glial cells in the conceptual picture of the brain,” it 
is astonishing to realize that the same work conducted almost a 
century ago is still directing our present-day view, understanding 
and research of microglia (40). A timeline of the main tools and 
methods that revolutionized and critically contributed to eluci-
date microglial cells identity, ontogeny, and function is listed on 
Figure 2.
This journey has started in the mid-nineteenth century with the 
introduction of the concept of neuroglia (“Nervenkitt,” meaning 
nerve-glue) by Rudolph Virchow in 1856 [for historical review, 
see Ref. (40–43)]. Neuroglia consisted of a mesodermal connec-
tive tissue, the interstitial matter, likely of acellular origin, which 
major function was to fill in the spaces around the neurons and 
keep them together (“Zwischenmasse”). Such concept excluded 
any cellular elements within the neuronal tissue. Nevertheless, 
the first description of a neuroglial cell was a radial cell of the 
retina made by Heinrich Müller in 1851 (today known as the reti-
nal Müller cell), years before Virchow introduced the concept of 
neuroglia (40, 41). Noteworthy, Virchow, Müller, and many others 
strikingly detailed neuroglia in their drawings using unstained 
tissue. Prominent discoveries regarding the morphological char-
acterization and the cellular origin of glial cells arose from the 
inspiring efforts of histologists and anatomists such as Camillo 
Golgi (1843–1926), Santiago Ramón y Cajal (1852–1934), and 
Pio Del Rio Hortega (1882–1945).
The “Third element” within the CNS
In the early 1870s, a major breakthrough in neuroglia was 
empowered by Camillo Golgi and his famous “Reazione nera” 
(Black reaction) (44) [for more details, see Ref. (45)]. The paraffin 
sections and their microscopic observation allowed for the first 
time to see the whole neuronal and neuroglial tissue stained in 
black against a light yellow background. Although the staining 
did not permit to differentiate between neurons and neuroglia, it 
allowed to obtain the best images so far of neurons and neuroglia. 
Golgi was the first to represent the glial cells as a distinct cellular 
population from neurons (41). He also reported a diversity of 
glial cells in the white and gray matter and found that the glial 
processes contacted both blood vessels and nerve cells. The latter 
discovery led him to postulate the first theory regarding the glial 
function, that neuroglia was mostly responsible for the metabolic 
support and substance exchange of neurons. These functions 
were later on assigned to astrocytes (41, 45, 46).
Further progress in the study of neuroglia was made possible 
by Santiago Ramon y Cajal and his pupils. Although the name 
of Cajal is often associated with the “Neuron doctrine” of the 
brain structure using the Golgi staining to characterize neurons 
morphology of the neuronal circuits, Cajal laboratory arduously 
worked in deciphering the glial enigma by developing new stain-
ing and microscopic tools that allowed to identify, classify, and 
functionally characterize the glial cells. In 1913, Cajal introduced 
an improved technique, the gold chloride-sublimate staining, 
which significantly enhanced microscopic visualization under 
a light microscope of neuroglial cells specifically (47). Cajal’s 
method improved the visualization of the nucleus and other 
cellular elements, in contrast with the Golgi’s black reaction that 
did not distinguish these elements from the dark staining of the 
background. This method was selectively staining both proto-
plasmic and fibrous astrocytes. Using the gold chloride-sublimate 
staining and considering solely the morphological visualization, 
Cajal reported a new class of cells describing them as “corpuscles 
without processes,” thus introducing the controversial “third ele-
ment” within the CNS to further discriminate this group of cells 
from neurons and astroglia, respectively the first and the second 
elements [for historical details, see Ref. (40–43, 45)].
Camillo Golgi and Santiago Ramon y Cajal were brilliant 
pathologists, and their merit and contributions to science were 
so notable that both were honored with the Nobel Prize in 
Physiology or Medicine in 1906 (48, 49).
Microglia: “The True Third element” 
identified by Rio Hortega
The “third element” postulated by Cajal was later refined by one of 
his pupils, Pio Del Rio Hortega. As “what we observe is not nature 
itself, but nature exposed to our method of questioning” (Werner 
Heisenberg), a student of the Cajal school, Rio Hortega learned 
the staining methods of Golgi, Cajal, Achúcarro and others, and 
developed his own method, a modification of Achúcarro’s ammo-
niacal silver staining (43, 50). This approach allowed to selectively 
stain microglia and permitted to remarkably visualize glial cells 
under a light microscope (51). Using his famous silver-carbonate 
method, Rio Hortega has been able to deeply characterize the 
FigURe 2 | Timeline of the main techniques and methodologies used in microglia research. Major approaches that have contributed to breakthrough 
findings to elucidate microglial cells identity, ontogeny, and function.
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morphology of two independent cell types, which he called 
microglia and interstitial cells, later renamed by him as oligo-
dendrocytes. This method allowed the visualization of the finer 
micelles that impregnated with prime detail the broad morphol-
ogy of such cells (40, 41). Moreover, Rio Hortega realized that 
what Cajal reported as a new class of cells depicted as “corpuscles 
without processes” was in fact a limitation of his gold chloride-
sublimate method that did not allow the complete observation 
of these cell processes (41). Henceforth, based on morphological 
and functional differences, Rio Hortega re-categorized Cajal’s 
“third element” as microglia, “the true third element,” placing 
oligodendrocytes together with astrocytes as the second element 
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of the CNS. The level of details of his morphological observations 
as well as the sharpness of his drawings are amazingly resembling 
the ones that are obtained with the current strategies used to label 
microglia, such as immuno or transgenic labeling. Notably, Rio 
Hortega’s detailed cytological observations and statements are still 
rather valid today (28, 41, 52). Rio Hortega was one of the most 
important figures in microglia research; his visionary studies and 
technical brilliance have undoubtedly paved the foundations for 
the modern research of microglia.
In 1930, Isaac Costero, a prominent student of Rio Hortega, 
implemented the first in vitro culture method of microglial cells 
from human brain and recorded their activity using time-lapse 
cinemicroscopy [(53) for historical details, see Ref. (40, 42)]. His 
findings were particularly notable in that time since they already 
echoed microglia motile ability, a process that would only be 
clearly demonstrated almost one century later (30, 31).
The Rise of the Modern Research
A modern era in microglia research occurred in the sixties, 
when George Kreutzberg in 1968 implemented the facial nerve 
lesion model in rodents to study axonal regeneration. The novel 
insights this model made possible included the study of micro-
glial responses to injury without blood–brain barrier disruption, 
as well as the first observational differentiation of microglial 
responses from that of infiltrating mononuclear phagocytes. 
By using light and electron microscopic and auto-radiographic 
ultrastructure techniques, Kreutzberg aimed to identify the cells 
implicated in the regenerative process after the disruption of the 
facial nerve (54). Using this model, microglia and astrocytes were 
pointed as major players involved in peripheral nerve regenera-
tion and degeneration. Thus, a major turning point came with 
the revelation that activated microglia physically interact with 
neurons by removing synaptic inputs. This feature, known as 
“synaptic stripping,” has been further described later in the cer-
ebral cortex also by 3D electron microscopy (55, 56). These find-
ings uncovered for the first time a potential neuroprotective role 
for microglia in neuronal regeneration. In the period preceding 
the introduction of this concept, microglial function was thought 
to be merely related to phagocytosis and to the engulfment of 
damaged neuronal cellular bodies (54, 57).
In the late 1980s, the immunohistochemical methods were 
replacing the conventional histochemical staining, which allowed 
not only to study microglial cell phenotypes and distribution, 
but also enabled the characterization of other cell types within 
the CNS (21, 58, 59). To specifically analyze microglial cells, it 
became urgent to be able to discriminate between microglia from 
brain monocyte-derived macrophages, since the main markers 
are shared between these cells. In 1991, Jonathon Sedgwick 
proposed an immunophenotypic discrimination through fluo-
rescence-activated cell sorting (FACS) to distinguish parenchy-
mal microglia (CD11b+CD45low) from other CNS macrophages 
(CD11b+CD45high) (60). The significance of this method was 
exceptional since it allowed for the first time to target microglia 
in their biological environment. Although not new, this approach 
quickly propagated the usage of discontinuous percoll gradients 
for isolating microglial cells from adult brains (60). Noteworthy, 
this technique is still the most used approach to specifically 
isolate resident microglia from CNS macrophages and infiltrating 
peripheral immune cells. In this context, a few years later, ionized 
calcium binding adaptor molecule 1 (Iba1) was reported to be 
expressed by mononuclear phagocytes and, within the CNS, by 
microglial cells. Iba1 was detected in all morphological and func-
tional forms of microglia in both rodents and human (61, 62) and, 
since then, it has been widely used as a microglial marker in vitro 
and in  vivo. Yet, recent expression profile studies revealed the 
expression of Iba1 in CNS macrophages, neutrophils, and mono-
cytes (12), thus making the discrimination between recruited or 
infiltrating macrophages from CNS-resident microglia difficult.
Tools to Study Microglia In Vitro
Although microglia cultures dated already from 1930 (53), it took 
50 years to develop and improve in vitro methods to obtain and 
culture high numbers of microglia derived from rodent brains 
and to deeply study microglia biology (63), shortly after enriched 
cultures of astroglia and oligodendroglia being described (64). 
Henceforth, studies were developed to culture fetal and adult 
microglia (65–68). The development of in  vitro cultures was 
indubitably an innovative tool that contributed to a greater 
characterization of microglia at several levels, which were not 
possible to be studied in  vivo. This included the identification 
of polarization states, the interaction with other CNS cell types, 
the expression of neurotrophic and neurotoxic factors, pro- and 
anti-inflammatory cytokines, neurotransmitter receptors, and 
mitogen receptors (69–79). It was in this context that both micro-
glia morphological transformation and immune functions were 
studied, and the concept of microglia as “pathological sensor” of 
the CNS environment emerged (80).
In the 1990s, protocols for isolating microglia from both 
neonatal and adult origin were developed. However, they were 
time-consuming and resulted in low yield of cells, which limited 
the functional study of microglia at the cellular and biochemical 
level. The most widely used method for the isolation of glial cells 
was the mechanical shake-off (64), which is based on differential 
adherence properties exhibited by the cells into the culture dish. 
Although several variations of this protocol were used worldwide, 
the introduction of a magnetic cell sorting using CD11b microbe-
ads improved not only the yield of microglial cells in comparison 
to the shake-off method but also allowed the accurate separation 
of microglia from astrocytes (81, 82).
In an attempt to overcome the low yield and time-consuming 
approaches, new in vitro models, such as immortalized cell lines, 
started to emerge. In 1985, Blasi and colleagues successfully 
immortalized murine bone marrow-derived macrophages by 
infecting the cells with two retroviral oncogenes, raf and myc (83). 
Five years later, the same approach was adopted to develop the 
BV2 microglia cell line. The BV2 cells were shown to share several 
biochemical features of microglial cells (84). Chronologically, the 
N9 microglial cell line was the first to be generated via infecting 
primary microglial cells with the v-myc or v-mil oncogenes (85). 
Overall, the generation of microglial cell lines represented a new 
and limitless in  vitro model for studying microglia properties. 
Since then, a variety of microglial cell lines from mouse, rat, or 
human have been developed and used for microglia research 
(Table 1). However, despite their universal usage, immortalized 
TAbLe 1 | Overview of a variety of commonly used microglial cell lines.
Name Organism immortalization 
method
Reference
N9/N13 Mus musculus v-myc/v-mil oncogenes Righi et al. (85)
BV2 M. musculus v-raf/v-myc oncogenes Blasi et al. (84)
RBM129 Rattus 
norvegicus
SV40 large T antigen Hosaka et al. (88)
CHME Homo sapiens SV40 large T antigen Janabi et al. (89)
EOC M. musculus Spontaneous Walker et al. (90)
C8-B4 M. musculus Spontaneous Alliot et al. (91)
MG5 M. musculus p53-deficient mice Ohsawa et al. (92)
MLS-9 R. norvegicus – Zhou et al. (93)
Ra2 R. norvegicus Spontaneous Sawada et al. (94)
HAPI R. norvegicus Spontaneous Cheepsunthorn et al. (95)
HMO6 H. sapiens V-MYC oncogene Nagai et al. (96)
MG6 M. musculus c-myc oncogene Takenouchi et al. (97)
SIM-A9 M. musculus Spontaneous Nagamoto-Combs et al. 
(98)
IMG M. musculus v-raf/v-myc oncogenes McCarthy et al. (99)
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cell lines are prone to an increased inflammatory status and are 
sensitive to genetic drift and morphological changes. Additionally, 
recent studies have being pointing critical differences between 
these cell lines and primary microglial cells (86) as well as acutely 
isolated microglial cells (15, 87).
An alternative strategy to cell lines and primary cultures 
generated from neonatal or adult rodent brains took advantage 
of embryonic stem (ES) cells. Tsuchiya  and colleagues described 
the first method to obtain microglial cells from ES cells in vitro 
Takahiro with Tsuchiya. Using a classical protocol to induce ES 
cells differentiation into tyrosine hydroxylase positive neurons, 
the authors succeeded in isolating a subpopulation of Iba1+ and 
CD45+ cells based on a density gradient (100, 101). The isolated 
population was shown to expand in high number and form 
mature microglial cells, to be functionally and morphologically 
identical to primary microglia, and to specifically migrate to the 
brain rather than to the periphery after transplantation. Of inter-
est, this classical protocol of neuronal differentiation from ES 
cells displays neurogenesis (101) and yolk sac-like hematopoiesis 
(102), thus reflecting microglia development in  vivo. Since 
these ES cells-derived microglia were not proven to proliferate 
or survive under culture systems, new improved protocols to 
explore the potential of these microglial precursor cells have been 
developed in the following years (38, 103–105).
The Characterization of Microglia In Vivo
Culture-based systems have provided the majority of the knowl-
edge about microglial biology. However, it is becoming unequivo-
cal that, under these conditions, microglial cells loose much of 
their singularities, thus resembling more to a macrophage-like 
cell (15, 16). Therefore, elucidating the effective roles of microglia 
in the CNS requires the development of tools that allow their 
study and manipulation in their biological environment. Such 
approaches include, for example, genetic modification strategies. 
In the CNS, the expression of the fractalkine receptor (CX3CR1) 
is restricted to microglial cells, whereas the expression of its 
ligand, the fractalkine, is specific to neurons. Taking advantage 
of the specificity of CX3CR1, Jung and colleagues developed 
the first genetic animal model allowing to target microglia, the 
Cx3cr1GFP knock-in mouse model (106). The murine Cx3cr1 
gene was replaced by a reporter gene encoding enhanced green 
fluorescent protein to generate a Cx3cr1-null locus. However, 
once more, gene-profiling data have recently shown that Cx3cr1 
is also expressed by other mononuclear phagocytes and that it 
is less microglia specific when compared with other recently 
identified microglia signature genes (15, 107). Moreover, since 
the insertion of the reporter gene in Cx3cr1GFP mice generates a 
Cx3cr1-null locus, this approach resulted in mice heterozygotes 
or homozygotes for the fractalkine receptor (106). However, 
although homozygous CX3CR1 deficiency dysregulates micro-
glial responses resulting in neurotoxicity (108), no microglial 
phenotype has been so far reported for heterozygote animals 
when compared to mice harboring the GFP transgene under the 
Iba1 promoter (109, 110). Taken together, the use of this animal 
model is still having a tremendous impact, and opened the doors 
to the development of new genetic strategies to target microglia 
(111).
Another approach to circumvent the disadvantage of in vitro 
methods was the development of in vivo/ex vivo culture systems 
mimicking microglial behavior in their biological environment. 
Mouse organotypic hippocampal slice cultures (OHSC) were 
implemented in 1981 and, since then, they have been used and 
optimized as a model recapitulating an in vivo-like situation, thus 
allowing the study of the intrinsic functional and physiological 
mechanisms of the nervous system (112, 113). Taking advantage 
of the OHSC model, the laboratory of Knut Biber in Freiburg 
expanded their use and implemented this culture system to study 
adult microglia physiology (114, 115). In the OHSC, ramified 
microglia was recently reported to exert a neuroprotective func-
tion against N-methyl-d-aspartate-induced excitotoxicity (115). 
Most of the in  vitro culture systems are based on the isolation 
of microglial cells from the brain, meaning that microglia is 
being studied outside of their biological context. In fact, much 
of the controversies relying on microglia behavior and function 
are likely the result of using experimental methods that are far 
from the physiological conditions. To overcome this obstacle, 
Masuch and colleagues improved their OHSC methodology by 
using microglial cells isolated from adult mice to replenish OHSC 
depleted of endogenous microglia. This model creates an in vivo-
like environment that allows the functional study of different 
microglia phenotypes to be easily accessed in vitro (115, 116).
The Discovery of Microglia Dynamics
For decades, microglia were seen as static cells displaying a “rest-
ing” phenotype under homeostatic conditions with the capacity 
to become “activated” when reacting to external stimuli (28, 35). 
As “the real voyage of discovery consists not only in seeking new 
landscapes, but in having new eyes” (Marcel Proust), this view 
has dramatically changed with the advance of microscopic tools 
that permit the “real-time” in vivo imaging of microglia in their 
physiological environment. Using a combination of the most 
recent tools at that time, such as the Cx3cr1GFP mouse model and 
2-photon in vivo fluorescence microscopy (a mildly non-invasive 
technique which achieves an imaging resolution of 100–200 μm 
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of the mouse cerebral cortex), one of the most extraordinary find-
ings that changed our knowledge about microglia biology was 
uncovered: microglial cells display a highly dynamic cell motility 
and plasticity in their fully ramified forms within the healthy 
brain, features that are unique to this cell type within the CNS 
(30, 31). Moreover, in vivo laser-induced CNS damage confirmed 
microglia morphological transformation and responses to local 
brain injury (30). It is worth to mention that, already in 1930, 
Costero suggested the motile nature of microglia, although the 
rudimental technology of his time limited definitive conclusions. 
It took 75 years since then to develop sophisticated microscopic 
imaging techniques to actually visualize microglia in their physi-
ological environment, in vivo, and in three dimensions at the same 
time (31). Imaging studies were previously widely performed 
in brain slices to characterize microglial electrophysiological, 
morphological, biochemical, and pharmacological properties. 
Nevertheless, histological approaches did not allow to capture the 
interactions occurring within and between cells, the responses 
to stimuli, injury, or disease as well as the motile behavior of 
microglia (42).
Exploring the combined application of the 2-photon micros-
copy with microglia expressing fluorescent proteins in vivo will 
greatly continue to contribute to unveil crucial roles regarding the 
function of microglia (and other CNS cell types) in the healthy 
adult brain, but also in the developing and aged brain, and in 
several disease models (117).
As active surveyors of their environment, microglia serve 
critical functions in the homeostatic brain and have been shown 
to influence neuronal activity (30, 31). Therefore, dissecting the 
functional aspects of such processes requires a real-time observa-
tion of microglia performance in the living brain. In that regard, 
advances in imaging technologies associated with sophisticated 
transgenic cell labeling methods have greatly contributed to the 
understanding of microglial interactions with other cells. Because 
of their transparency, the zebrafish larvae and embryos offer a 
powerful in vivo high-resolution imaging of the dynamic inter-
actions occurring within cellular and subcellular mechanisms 
(118). Interestingly, it also enables the visualization of the entire 
microglial cell network (25–30 cells) (119). In 2008, Francesca 
Peri, by generating lines of transgenic zebrafish that allowed 
differential labeling of various nervous system cells, developed 
a model for studying neuronal–microglial interactions. This 
approach demonstrated for the first time the dynamism of 
neuronal phagocytosis by microglia, in real time, and revealed 
the involvement of v0-ATPase proton pump in phagosomal-
mediating vesicles fusion (120).
The Origin of Microglia and CNS-Resident 
Macrophages
Microglial ectodermal vs mesodermal origin was a matter of 
extensive debate until recently. Upon Rio Hortega concept of 
“microglia” to distinguish oligodendrocytes from the true meso-
dermal elements, the ectodermal origin of glial cells was generally 
accepted (52). Given the phenotypical semblance of microglia to 
other macrophage populations, their myeloid origin was read-
ily accepted. Even Rio Hortega himself believed that microglia 
could derive from blood circulating monocytes that invade 
the CNS, replacing the embryonic microglial cells. However, 
it was only recently demonstrated that microglia belong to the 
myeloid lineage (8, 10, 121). Using elegant transgenic fate map-
ping strategies to trace microglia precursors, it was revealed that 
microglia derive from primitive yolk sac myeloid progenitors that 
enter the CNS between embryonic days 8.5 and 9.5, rather than 
hematopoietic-derived cells. Briefly, mice expressing tamoxifen-
inducible MER-Cre-MER recombinase gene under the control 
of the runt-related transcription factor 1 (Runx1) locus were 
crossed with a Cre-reporter mouse strain. A single injection of 
4-hydroxytamoxifen given to pregnant females induces recombi-
nation in a 12-hour period, which leads to irreversible expression 
of fluorescent protein in RUNX1+ cells and their progeny in the 
knock-in embryos (122). Despite the fact that yolk sac, but also 
fetal liver progenitors express Runx1, at the embryonic day 7.5 
only yolk sac progenitors are expressing Runx1, therefore, the 
tamoxifen-induced recombinase will only irreversibly tag yolk 
sac’s concomitant progeny. Moreover, the authors showed that 
adult microglia are maintained independently of definitive 
hematopoietic progenitors. To corroborate the notion that 
microglia are a distinct immune cell population independent 
from peripheral monocytes circulation, fate mapping strategies 
coupled with 12-color flow cytometry analysis were recently 
used to show that retinal microglia and monocyte-derived 
macrophages exhibit a distinct phenotypic signature. Moreover, 
this retinal microglia-specific profile (CD45low CD11clow F4/80low 
I-A/I-E−) is stable under physiological or injury conditions (123). 
Such sophisticated methodologies are contributing greatly to 
decipher the unique features and functions of microglial cells 
under physiological and pathological conditions.
Similarly to microglia, it was recently shown that non-
parenchymal CNS meningeal, perivascular, and choroid plexus 
macrophages are also derived from hematopoietic precursors, 
establishing stable populations throughout life span with 
self-renewal capacities (107). Among non-parenchymal CNS 
macrophages, meningeal and perivascular macrophages do 
not rely on circulating blood monocytes, while choroid plexus 
macrophages, which display a dual origin and a shorter turno-
ver, partially depend on circulating blood cells (107). Yet, it is 
important to highlight that despite their ontogeny similarities, 
microglia are the only “immune” cells populating the CNS 
parenchyma, thus displaying unique features to serve critical 
functions associated to it. Nevertheless, non-parenchymal mac-
rophages are strategically located at the brain boundaries and 
represent distinct and specialized populations of macrophages 
serving as key mediators for brain homeostasis and immune 
responses (107, 124, 125). Although it has been arduous to 
specifically target the different brain immune cells, perivascular 
macrophages have been recently discriminated from microglia 
by their expression of the mannose receptor (CD206) (107, 124, 
125). Conversely, the P2Y12 receptor has been shown to be 
expressed by parenchymal microglia, yet absent in perivascular 
and meningeal macrophages (107, 126). Taking advantage of 
CD206 differential expression, it was recently demonstrated that 
both perivascular macrophages and microglia are the primary 
source of the chemokine CCL2, which mediates the infiltration 
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of CCR2+ monocytes to the brain, exacerbating the neuroinflam-
matory environment occurring after status epilepticus (125). 
Moreover, it has been shown that perivascular macrophages 
mediate neurovascular and cognitive dysfunction induced by 
hypertension through their capacity to produce reactive oxygen 
species and inflammatory cytokines. Intriguingly, perivascular 
macrophages depletion with clodronate was sufficient to recover 
from neurovascular impairments (124). Specifically, Faraco and 
colleagues reported 60–65% reduction of CD206+CD45hiCD11b+ 
perivascular macrophages, yet the number of microglia and 
blood lymphocytes remained constant (124). As pharmaco-
logical strategies to efficiently deplete microglia are reported 
and used worldwide (127), such observations underline the 
need for discriminating between microglia and CNS-resident 
macrophages to understand their specific roles and clarify their 
truly homeostatic, neuroprotective, and neurotoxic roles.
genome-wide Analysis
In the last decade, genome-wide sequencing technologies have 
become quite attractive for researchers and started to be widely 
used as powerful tools to decipher microglial unknown and 
unique physiological roles in either isolated or cultured micro-
glia (11, 12, 14–20, 128–130). The Immunological Genome 
(ImmGen) Project was the first systematic study covering the 
expression profiles of murine macrophages from different 
organs. Using these data, Gautier and colleagues observed a 
high diversity among tissue-resident macrophage populations, 
suggesting their flexibility to adapt to their environment, but 
also revealed a unique expression profile intrinsic to microglial 
cells (11). This work opened the door for more sophisticated 
strategies allowing for the first time to identify a microglia-
specific gene signature (15). This approach not only opens 
up the potential to understand how microglial cells behave 
in health and disease but also provides opportunities for the 
discovery and generation of genetic tools that could specifically 
target microglia. Moreover, applying such techniques to identify 
unique molecular signatures in both microglia and non-paren-
chymal macrophages are expected to challenge and shape our 
current understanding regarding the immune cell populations 
residing in the brain (107).
A SYSTeM APPROACH TO bUiLD THe 
MiCROgLiOMe
As the immune effector cells of the CNS, microglia are central 
in shaping homeostatic, neuroprotective, degenerative, and 
regenerative outcomes under different conditions. Recently, the 
use of modern sequencing technologies coupled with improved 
methods to enrich and to acutely purify microglia and other types 
of brain cells, greatly empowered the awareness of microglial 
uniqueness, properties, and complexity (Figure 3). These recent 
studies reveal a unique repertoire of transcripts selectively and 
specifically expressed by CNS-resident microglia that distinguish 
them from other CNS and peripheral cells, exposing other 
non-immune functions hitherto unforeseen of microglial cells 
(Table 2) (11, 12, 14–20, 128–130). The description of microglia 
gene signatures as well as their transcriptional changes associ-
ated with several brain diseases has also been recently accurately 
revised (131, 132). These systematic transcriptome datasets are 
fundamental to understand the gene expression patterns of both 
healthy and diseased tissues, thus allowing studies of brain cel-
lular types aiding in elucidating the mechanisms associated to 
different CNS pathological processes, such as neurodegenerative 
diseases. For example, the microglia-unique gene signature is 
specifically modulated in normal brain aging compared to the 
young brain or under different neurological diseases (12, 14, 18).
In the present context, to allow a fast and easy comparison of 
these genome-wide transcriptome profiles, new databases, such 
as Glia Open Access Database, available via www.goad.education 
have been established (133).
Driven by technological advancements, high-throughput 
-omics methods, such as genomics, transcriptomics, proteomics, 
and metabolomics seek the thorough description of changes in 
genes, transcripts, proteins, and metabolites, respectively. These 
system approaches have emerged as precious ways to interrogate 
several features of CNS uniqueness under healthy and diseased 
conditions. More importantly, they have made the molecular 
study of critical features of the different cell types that populate 
the brain possible.
Taking advantage of the data generated by these high- 
throughput studies, the “microgliome” is starting to emerge 
(Table  3). Here, we define the “microgliome” as the different 
-omics that characterize microglia under specific conditions, 
such as homeostasis, injury, or disease.
At the epigenetic level, the gene expression profile of the 
environment-triggered signal-dependent specific factors are 
critical for microglia identity and are able to alter gene expres-
sion and gene enhancer profiles (16, 17, 130). Specifically, distinct 
tissue environments drive divergent programs of gene expression 
by differentially activating a common enhancer repertoire and 
by inducing the expression of differing transcription factors that 
collaborate with the macrophage lineage-determining factor 
PU.1 to establish tissue-specific enhancers (16). As previously 
mentioned, the microglia transcriptome is the unique set of 
transcripts expressed by microglial cells when compared to other 
brain and peripheral immune cells. The microglia proteome is 
defined as the unique array of proteins selectively expressed by 
microglial cells under homeostatic conditions (14, 15).
In some of the cited studies, the authors have started to list 
microglia-specific genes based on their cellular localization or 
function. In this regard, for example, Hickman and colleagues 
described a “microglial toolset for sensing changes in the 
brain’s milieu,” namely the “microglia sensome” (Table 4) (14). 
Similarly, the microglia “surfaceome” has been designated as the 
microglia-unique expression of cell surface molecules (15, 128). 
The “microglia sensome” is required to maintain the CNS homeo-
static status and defines the threshold to which critical transitions 
between CNS homeostasis and pathology can be identified and 
compared. Highlighting the unique adaptation of microglia to the 
CNS parenchyma, the “macrophage sensome” is distinct from the 
one described for microglial cells (Table 4) (14).
Furthermore, emerging data have been highlighting a brain-
gut crosstalk that is critically modulated by the gut microbiota 
FigURe 3 | Continued
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(134). The microbiota consists in the specific microflora that colo-
nizes an established microenvironment, such as the gut. Recently, 
the impact of the host gut microbiota on microglia homeostasis 
has started to be addressed. Such studies support a critical role 
for host microbiota in shaping microglia maturation and immune 
function. The microglia-specific microbiome is defined as the host 
bacteria that maintain and shape microglia maturation, develop-
ment, and functions, encompassing microorganism-induced 
transcriptomic changes in microglial cells (129, 130). These 
studies address the impact of host microbiota in microglia under 
specific conditions, such as germ-free and specific-pathogen-free 
environments. Specific genes that are precisely affected by the 
host microbiota conditions have been identified (Bcl, Ccnd3, 
Cdk9, Csf1, Ddit4, Nfkbi-α, Sfpi1) (129, 130).
As a perspective, the “microgliome” will be built based on 
the data generated at different -omics level in order to associ-
ate specific microglial phenotypes to each defined condition, 
such as homeostasis, injury, or disease. Moreover, the fact that 
microglia exist under several forms, are highly dynamic and 
highly sensitive to specific cues, emphasize the importance of 
compare whether their profile is closely reflected when they are 
cultivated in vitro. Thus, in vivo vs in vitro “microgliomes” are 
also foreseen.
CONCLUDiNg ReMARKS
Since the description of Rio Hortega’s staining method to distin-
guish microglia from the surrounding cells, advanced techniques 
and tools over years and decades have contributed to elucidate the 
origin of microglial cells as well as their functions during develop-
ment and in the adult brain under healthy or diseased conditions. 
Recently, molecular profiling of freshly isolated adult microglial 
cells have once and for all shown that microglia are distinct from 
other immune cells of the CNS as well as from other mononuclear 
phagocytes. The unique features of these cells are essential to 
fulfill their critical functions in their environment. The distinc-
tion of microglia from other myeloid cells is fundamental for 
understanding their specificity in brain development, function, 
FigURe 3 | Continued  
workflow illustrating technical and methodological details used in the main genome-wide gene expression profiling studies. The related results are 
shown in Table 2. MA, microarrays; RNA-seq, RNA-sequencing; DRS, direct RNA sequencing; 2D-DIGE, two-dimensional difference gel electrophoresis; ChIP-seq, 
chromatin immunoprecipitation sequencing; ATAC-seq, assay for transposase accessible chromatin; iChIP, indexing-first chromatin immunoprecipitation.
10
Sousa et al. Discovering and Characterizing Microglia
Frontiers in Immunology | www.frontiersin.org March 2017 | Volume 8 | Article 198
and disease. Difficulties in addressing microglia functions were 
mostly related to limitations in isolation protocols and lack of 
techniques or specific markers to specifically target these cells. 
Genome-wide profiling of acutely isolated cell populations have 
opened up new opportunities for the identification of microglia-
specific markers distinct from other myeloid cells to precisely 
address microglia functions (20). For these ex vivo techniques, 
the significance of isolating microglia from their context (135) 
as well as the fact that microglia processes, which possess funda-
mental functions, might be lost during their isolation procedure 
(131) must be still taken into account.
It is believed that many CNS diseases are strengthened by 
inappropriate microglial cell functions, therefore understand-
ing the specific molecular triggers and analyzing the resultant 
gene expression signatures that characterize microglial cell 
phenotypes is a fundamental step. Supporting this hypothesis, 
the generated genome-wide profiles suggest that microglia are 
likely to display unique and characteristic gene signatures 
depending on the CNS disease [for revision, see Ref. (131, 132).]. 
In this context, transcriptomic profiles of mouse microglia 
from distinct brain regions revealed a considerable regional 
immune-phenotypic diversity across the adult lifespan and an 
interregional dependency on microglial aging phenotype (136). 
Microglial expression profiles were also shown to be subtly 
distinct between different rat brain regions (137). Yet, microglia 
maintain a specific core signature that, independently of the 
brain regions, differentiates them from other macrophages 
(136). This unique microglia transcriptional profile has been 
recently described in zebrafish (138) and in human microglial 
cells (20, 126, 139). Taken together, these genome-wide stud-
ies are deeply contributing to uncovering the involvement of 
microglia in different CNS processes and are opening the doors 
to the identification of microglial specific targets that may have 
potential therapeutic values (140).
TAbLe 2 | Mouse microglia unique or highly expressed genetic profiles.
Condition Cell comparison Omics Microglia-selective or highly expressed genes Remarks Reference
Healthy Brain mg vs p mØ red pulp 
mØ and lung mØ
Transcriptome Crybb1, Cx3cr1, Fcrls, Itgb5, Olfml3, Sall1, Siglech, Smad7, 
Socs3, Tmem119, Trem2
Distinct molecular signatures among tissue macrophages
Tissue-specific environment adaptation
Gautier et al. (11)
Sensome
Disease (ALS) Brain mg vs astroglia, spinal 
cord, NO, ph mØ and mo
Transcriptome Olfml3, Siglech, Tmem119 Iba1 (Aif1) and CD68 not specifically expressed by mg Chiu et al. (12)
Sensome Cx3cr1 not as specific as Olfml3, Tmem119, or Siglech
Mg genomic profiles likely to be disease-specific
Aging Brain mg vs astrocytes Transcriptome Young mg: Ccl2, Ccl24, Ccl7, Ccr6, Clec4d, Ifitm1, Plbd1, Slpi Inflammatory responses associated with young mg Orre et al. (18)
Aged mg: Ccl3, Cd3e, Cd4, Lyz1, P2ry12, Pik3c, 
Rdh12Tnfs12, Tnfsf13b, Wbscr22
2.5 vs 15–18 months old
Aging Brain mg vs whole brain, pmØ Transcriptome Mg sensome: Ccr5, Cd53, Csfr1, Cx3cr1, Grp34, Hexb, Itgb5, 
Ly86, P2ry12, P2ry13, Selplg, Siglech, Tgfbr1, Tmem119, 
Trem2, Tyrobp
Mg transcriptome: Adora3, Camp, Cxcr1, Fcrls, Gp34, Hexb, 
Olfml3, P2ry12, Rnase4, S100A8, S100A9, Siglech, Tmem119, 
Trem2
Young mg: Adora3, P2ry12, P2ry13, Siglech, Tgfb1, Trem2, 
Tyrobp
Aged mg: Cxcr4, Ifitm, Il-1b, Lgals3, Tnf
Mg proteome: Ckb, Ldhb, S110-a9, Dpysl2, Eno3
Mg phenotype shifts toward an alternative neuroprotective priming 
state (Stat3 and neuregulin-1) during aging
81% of the sensome genes are down-regulated during aging and 
involved in sensing endogenous ligands
Normal aging distinct from neurodegenerative diseases
5- vs 24-month-old
Hickman et al. 
(14)Sensome
Proteome
Healthy ESdM vs primary mg, 
astrocytes, neurons, BMDC, 
BMDMs, T cells, brain mg
Surfaceome Cd40, Cmtm4, Krtcap2, Lpcat3, Lrp8, Mcoln3, Mfsd10, 
Pap2c, Slc30a5, Slco4a1, Stab1, Tmem48, Tmem55b
ESdM and culture mg display similar transcriptomes Beutner et al. 
(128)
Healthy Brain mg vs neurons, 
astrocytes, oligodendrocytes, 
pericytes
Transcriptome Bcl2a1a, C1qa, Ccl2, Ccl3, Ccl4, Ccrl2, Cd83, Cebpa, Csf1r, 
Cst3, Cx3cr1, Gp34, Gp84, Hexb, Il1a, Irf5, Irf8, Itgam, Ly86, 
Olfml3, P2ry12, P2ry13, Plau, Rcsd1, Sfpi, Tgb1, Tmem119, 
Tnf, Trem2, Tyrobp
Glial cells display distinct genomic signatures Zhang et al. (19)
Alternatively spliced RNAs are specific for each cell type
lncRNAs: A430104N18Rik, Gm11974, Gm13476, Gm13889, 
Gm26532
Alternative splicing: Ablim1, Actn4, Adam15, Arhgef1, Eif4h, 
Ktn1, Mcf2l, Mprip, Palm, Pkp4
Healthy Brain mg vs large and small 
pmØ, TGEMs, BMDMs
Transcriptome
Epigenome
Cx3cr1, Grp56, Sall3 Freshly isolated mg- and large pmØ-specific gene expression profile 
greatly lost in culture
Gosselin et al. 
(16)Mg-specific binding sites for PU.1: Ctcf, Mef2, Nav2, Smad 
(consistent with Tgf-β signaling) Central nervous system environmental factors governs mg gene 
expression phenotypeMg-enhancer profile: MaFb, Mef2, Smad3, Stat3, Usf1
Healthy Brain mg vs kupffer mØ,  
spleen red pulp mØ, lung mØ, 
pmØ, small intestine mØ,  
large intestine mØ, mo
Transcriptome
Epigenome
Cx3cr1, Fcrls, Sall1, Siglech, Sparc Myeloid cells display distinct chromatin landscapes Lavin et al. (17)
Mg-specific binding sites PU.1: Mef2c Ontogeny and tissue microenvironment are critical to shape distinct 
mØ chromatin landscapesMg-enhancer profile: Mef2
(Continued )
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Condition Cell comparison Omics Microglia-selective or highly expressed genes Remarks Reference
Healthy Brain mg (E10.5–12.5; P4, 
P21, P30, P60) vs primary mg 
(P0-P1), cultured adult mg 
(M0, M1, M2a), human mg, 
blood monocytes, astrocytes, 
oligodendrocytes, hippocampal 
and cortical neurons, N9, BV2 
and RAW264.7 cell lines, ESdM,
Transcriptome
Surfaceome
Csf1r, Cx3cr1, Fcrls, Gpr34, Gpr84, Hexb, Itgb5, Olfml3, 
P2ry12, P2ry13, PU.1, Sall1, Siglech, Socs3, Tgfbr1,  
Tmem119, miR-342-3p, -99a, -125b-5p
Tgf-β1 is central for adult microglia development
Fcrls and P2ry12 as prospective mg-specific markers (mouse/human)
Mg-specific gene signature peaks between P21 and 2 months of age
Freshly isolated adult mg-specific gene expression profile greatly lost 
in culture
Butovsky et al. 
(15)
Surfaceome: Fcrls, P2ry12
Healthy Brain mg Microbiome GF vs SPF mg: Bcl, Ccnd3Cdk9, Csf1 (faintly increased), 
Ddit4, Nfkbi-α, Sfpi1 (Il-1α, B2m, Jak3, Stat1 decreased)
Host microbiota critically impacts microglia maturation, activation 
and homeostasis
Erny et al. (129)
GF mg display a hyper-ramified morphology, increased density and 
increased proliferative rate
Bacterial complexity critical for mg maintenance
SPF vs GF vs ASF
Healthy 
(development)
Brain mg (E17, P7, P14, 
P21, P60) vs astrocytes, 
oligodendrocytes; newly 
formed oligodendrocytes, 
myelinating oligodendrocytes, 
endothelial cells, myeloid cells, 
BMDMs, human mg
Transcriptome Adora3, Cx3cr1, Fcrls, Gpr34, Gpr84, Hexb, Il1a, Ltc4s, 
Olfml3, P2ry12, P2ry13, Selplg, Tmem119
Tmem119 proposed as a stable marker for mouse (and human) mg Bennett et al. 
(20)Tmem119 is limited to CD45lowCD11b+ mg
Mouse mg maturation occurs by P14
Tmem119 reactivity restricted to resident mg
LPS-treated mg downregulates the expression of several 
mg-specific genes such P2ry12, Tmem119, Fcrls, Olfml3, Ltc4s, 
and Adora3
Healthy 
(development)
Brain mg (YS; early mg: 
E10.5-E14; pre-mg: E14-P9; 
adult mg: from 4 weeks-old)
Transcriptome
Epigenome
Microbiome
YS: Crc2Csf1, Ctsb, Dab2, F13a1, Lfit3, Mcm5 Mg gene expression during development displays shifts in 
chromatin landscapes
Matcovitch-
Natan et al. (130)Early mg: Arid3a, Psat1
Pre-mg enhancers: Arid3a, Csf1, Psat1 Microbiome impacts mg development (specifically adult mg), 
physiological function and likely influencing neurodevelopment 
disorders
Adult mg: Crybb1, Egr1, Ets1, Fcrls, Fos, Irf8, Jun, MafB, 
Mef2a, Sall1
Specific features and findings related to each study are specifically described. Genes are listed in alphabetical order. mg, microglia; mØ, macrophages, mo, monocytes; NO, neutrophils; DC, dendritic cells; p, peritoneal; ph, peripheral; 
BMDMs, bone marrow-derived macrophages; TGEMs, thioglycollate-elicited macrophages; ALS, amyotrophic lateral sclerosis; miR, micro RNA; lncRNA, long non-coding RNA; GF, germ free; SPF, specific-pathogen free; ASF, altered 
Schaedler flora; ESdM; embryonic stem cell-derived microglia; YS; yolk sac [adapted from Ref. (131)].
TAbLe 2 | Continued
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TAbLe 4 | Microglia and macrophage sensome.
Microglia-specific sensome genes Macrophage-specific sensome 
genes
Camp Ahnak
Crybb1 Alox15
Cx3cr1 C4b
Fos Cd5l
Fcrls Cfp
Grp34 Crip1
Grp56 Cxcl13
Hexb Ecm1
Hpgd Ednrb
Itgb5 Emilin2
CMRF35-like molecule F5
Ngp Fabp4
Olfml3 Fcna
P2ry12 Fn1
P2ry13 Gm11428
Rnase4 Icam2
S100a8 Msr1
S100a9 Pf4
Siglech Prg4
Slc2a5 Ptgis
Slco2b1 Retnla
Syngr1 Saa3
Tgfbr1 Serpinb2
Tmem119 Slpi
Trem2 Thbs1
Top 25 sensome genes described by Hickman and colleagues (14) exclusively 
expressed in microglia (left column) or in macrophages (right column). Genes are listed 
in alphabetical order.
TAbLe 3 | Overview of the emerging mouse “microgliome” profile.
epigenome Transcriptome Proteome
Ctcf Crybb1 BIN1
Irf8 Csfr1 CKB
MaFb Cx3cr1 LDHB
Mef2 Fcrls LGMN
Nav2 Grp34 P2RY12
Sall1 Grp84 RGS10
Sall3 Hexb S100-A9
Smad3 Itgb5 TPPP
Stat3 Olfml3
Usf1 P2ry12
P2ry13
Rnase4
Siglech
Slc2a5
Smad7
Socs3
Tgfb1
Tgfbr1
Tmem119
Trem2
Tyrobp
miR-342-3p, -99a, -125b-5p
Reference
Gosselin et al. 
(16); Lavin et al. 
(17); Matcovitch-
Natan et al. (130)
Gautier et al. (11); Beutner et al. (128); Chiu 
et al. (12); Hickman et al. (14); Butovsky 
et al. (15); Gosselin et al. (16); Lavin et al. 
(17); Orre et al. (18); Zhang et al. (19); 
Bennett et al. (20)
Hickman et al. 
(14); Butovsky 
et al. (15)
Specific genes and proteins selected based on their high expression levels as 
described in the corresponding studies. Lists are in alphabetical order.
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In summary, it has been shown in  vivo that microglial 
activity is critical for normal brain development (27). Ex vivo 
microglial gene expression profiles from different physiological 
or pathological conditions show that they scarcely resemble to 
those classified as the classical polarization states (12, 33), while 
in  vitro microglia studies highlight their immune properties 
(7). Overall, the notion that microglia share a myeloid origin 
with other macrophage populations, thus inheriting features 
such as phagocytosis abilities, lead to the questioning about the 
real meaning of experimental observations on microglia as the 
“immune effectors” and “professional phagocytes” residing in 
the adult CNS. Are microglia immune features a result of their 
myeloid origin or an outcome of in vitro observations? Are micro-
glial cells essential for CNS host defense or are they professional 
phagocytes fundamental for brain development? Which cells are 
the real immune cells of the brain? Further investigations, taking 
advantage of the technological progress, need to be carried out to 
properly address these open questions. For example, single-cell 
transcriptomic and proteomic technologies are gaining their 
momentum to directly access gene and protein expression pro-
files (141–143). Their application to individual microglial cells 
will certainly uncover new magnitudes of cell heterogeneity and 
will contribute to further characterize microglial phenotypes and 
functions under physiological and disease contexts.
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